About IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences is a company based in Thunder Bay (Canada) founded in 2009. IgY Immune Technologies & Life Sciences has raised $65.1 thousand across 1 funding round. IgY Immune Technologies & Life Sciences offers products and services including Muno-IgY. IgY Immune Technologies & Life Sciences operates in a competitive market with competitors including Newtricious, Microcore, BiovaBIO and Nutriom, among others.
- Headquarter Thunder Bay, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Igy Immune Technologies And Life Sciences Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.1 K (USD)
in 1 rounds
-
Latest Funding Round
$65.1 K (USD), Seed
Feb 17, 2012
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences offers a comprehensive portfolio of products and services, including Muno-IgY.
Purified IgY protein for immune and gut health support
Funding Insights of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences has successfully raised a total of $65.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $65.1 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by IgY Immune Technologies & Life Sciences
Investment portfolio details for IgY Immune Technologies Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IgY Immune Technologies Life Sciences
Detailed financials for IgY Immune Technologies Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Igy Immune Technologies & Life Sciences Comparisons
Peer comparison for IgY Immune Technologies Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newtricious, Microcore, BiovaBIO and Nutriom, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Egg-based active ingredients are supplied for functional foods.
|
|
| Locked | Locked | Locked |
Develops and manufactures nutritional ingredients and medical foods for health applications.
|
|
| Locked | Locked | Locked |
Provides nutrients from eggshell membrane for skin and hair health support.
|
|
| Locked | Locked | Locked |
Manufactures high-quality egg white protein powder for health-conscious consumers.
|
Detailed competitors of IgY Immune Technologies Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Igy Immune Technologies & Life Sciences
Complete news archive for IgY Immune Technologies Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IgY Immune Technologies & Life Sciences
IgY Immune Technologies & Life Sciences was founded in 2009 and raised its 1st funding round 3 years after it was founded.
IgY Immune Technologies & Life Sciences is headquartered in Thunder Bay, Canada. It is registered at Thunder Bay, Ontario, Canada.
Terry Dyck is the current CEO of IgY Immune Technologies & Life Sciences.
IgY Immune Technologies & Life Sciences is a funded company, having raised a total of $65.1K across 1 funding round to date.
IgY Immune Technologies Life Sciences was founded in 2009 in Thunder Bay, Canada, focusing on biotechnology. Polyclonal IgY antibodies are derived from chicken eggs for human and animal applications in nutraceuticals and pharmaceuticals. These products support sectors including medicine, functional foods, agriculture, and cosmeceuticals, with non-specific types used in general supplements and specific types targeted at vaccine-resistant pathogens. The company was deemed deadpooled as of March 2018.
IgY Immune Technologies & Life Sciences's top competitors include Newtricious, Microcore and BiovaBIO.
IgY Immune Technologies & Life Sciences offers Muno-IgY.